Diabetes Obes Metab 23:529 Holst JJ (2019) The incretin system in healthy humans: The role of GIP and GLP-1
The recommended injection sites include the abdomen, thigh, and upper arm, rotating them with each dose to prevent pain, bruising, and skin thickening
The guiding principle is to find the lowest effective dose that comfortably sustains continued outcomes for the long term, rather than rushing everyone to the maximum dose in the minimum time
Table of Contents: How long does it take for semaglutide GLP-1 to work for weight loss
Unique Features: Semaglutide is the first GLP-1RA shown to reduce cardiovascular events in non-diabetic individuals, making it a notable choice for obesity management
It suggests that standard doses may already be achieving near-maximal effect in women, which has implications for how aggressively you need to escalate